IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Supernus Pharmaceuticals Inc

Q1 2017 vs Q2 2017

Comparing institutional holders between quarters

Quarters

Q2 2017Q1 2017Q4 2016Q3 2016Q2 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Goldman Sachs Group Inc
UNCHANGED
Shares50,000 from 50,000
Change0 (0%)
Value$407 (+$112)
Filed 2017-08-14
Wells Fargo & Company
UNCHANGED
Shares25,000 from 25,000
Change0 (0%)
Value$203 (+$55)
Filed 2017-08-10
683 Capital Management, LLC
CLOSED
Shares0 from 2,000,000
Change-2,000,000 (-100%)
Value$0 (-$11.8K)
Filed 2017-08-14
Status
Goldman Sachs Group Inc
UNCHANGED50,00050,00000%$295$407+$1122017-08-14
Wells Fargo & Company
UNCHANGED25,00025,00000%$148$203+$552017-08-10
683 Capital Management, LLC
CLOSED02,000,000-2,000,000-100%$11.8K$0-$11.8K2017-08-14
Showing 3 of 3 institutions